Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

Wandel v. Eisenberg

January 13, 2009

ARNOLD WANDEL, DERIVATIVELY ON BEHALF OF NOMINAL DEFENDANT, BED BATH & BEYOND, INC., PLAINTIFF-APPELLANT,
v.
WARREN EISENBERG, ET AL., DEFENDANTS-RESPONDENTS, BED BATH & BEYOND, INC., NOMINAL DEFENDANT-RESPONDENT.



Plaintiff appeals from an order of the Supreme Court, New York County (Charles E. Ramos, J.), entered May 18, 2007, which granted defendants' motion to dismiss the amended complaint.

The opinion of the court was delivered by: Saxe, J.P.

Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.

This opinion is uncorrected and subject to revision before publication in the Official Reports.

David B. Saxe, J.P., Eugene Nardelli, Karla Moskowitz, Rolando T. Acosta and Leland G. DeGrasse, JJ.

603665/06

Following this Court's recent reinstatement of a shareholder derivative action based upon claims that a majority of the board of directors knew or had enough specific information that they should have known of the company's practice of backdating stock options (see Matter of Comverse Tech., Inc. Derivative Litig., 56 AD3d 49 [2008]), we must now further consider the amount of knowledge and information necessary to establish demand futility.

In the wake of a wave of publicity disclosing that numbers of public companies had been backdating stock option grants, in June of 2006 two securities analysts, Merrill Lynch and Deutsche Bank, issued reports identifying nominal defendant Bed Bath & Beyond as a company whose stock option grant dates aroused suspicion of backdating. On June 19, 2006, the board of directors of Bed Bath & Beyond appointed a special committee of two independent directors to conduct an investigation.

On September 20, 2006, counsel for the special committee notified the SEC of its review, and the SEC commenced its own informal inquiry. On October 10, 2006, Bed Bath & Beyond made public the findings of its special committee, which had "identified various deficiencies in the process of granting and documenting stock options." The report acknowledged that "[s]ome hindsight was used in selecting some annual grant dates." Specifically, "[e]xcluding grants only to Form 4 filers beginning in 2003, almost all annual grant dates in 1998-2004 likely were selected with some hindsight," although this "hindsight" was relatively slight, in that grant dates were selected within a few trading days after the recorded date, and the individuals who selected the dates did not "appreciate the accounting or disclosure implications of the practices used for selecting those dates." Similarly, the special committee found that the people responsible for accounting and disclosure functions at the company were unaware of any of the improper date selection practices. It concluded that no person involved in the grant process had engaged in willful misconduct and, in particular, that the co-chairmen and chief executive officer believed that they were acting in the best interests of the company with the purpose of attracting and retaining employees.

Following the issuance of the report, the company adopted new controls in its stock option awards process. It also performed a financial analysis of the effect of adjusting for the option misdating. It determined that the adjustment of compensation charges for those years would have no material effect on its past financial statements, but that adjustment of the equity section of its consolidated balance sheet would be necessary. In addition, it reset the prices of unvested options to the appropriate levels.

Approximately nine days after Bed Bath & Beyond made public the special committee's findings, plaintiff brought the instant derivative action. Defendants moved to dismiss the complaint for failure to adequately plead demand futility, and the motion was granted. This appeal followed.

Business Corporation Law § 626(c) requires that a shareholder bringing a derivative action seeking to vindicate the rights of the corporation allege, with particularity, either that an attempt was first made to get the board of directors to initiate such an action or that any such effort would be futile. "The demand requirement rests on basic principles of corporate control -that the management of the corporation is entrusted to its board of directors, who have primary responsibility for acting in the name of the corporation and who are often in a position to correct alleged abuses without resort to the courts" (Bansbach v Zinn, 1 NY3d 1, 8-9 [2003] [internal quotation marks and citation omitted]). Therefore, the demand requirement is excused only when the complaint's specific allegations support the conclusion that "(1) a majority of the directors are interested in the transaction, or (2) the directors failed to inform themselves to a degree reasonably necessary about the transaction, or (3) the directors failed to exercise their business judgment in approving the transaction" (Marx v Akers, 88 NY2d 189, 198 [1996]).

The pertinent question here is whether the complaint alleges with the requisite particularity any of the grounds for excusing demand on the board of directors as futile. As to the first test for demand futility under Marx v Akers, the complaint fails to support the assertion that a majority of the directors should be treated as interested in the transaction. It is conceded that of the 10 individuals on the board of directors during the relevant period, three inside directors are alleged to have received backdated options and must therefore be treated as interested. However, the allegations as to the actions of the other directors are insufficient to establish that any of them were interested. There is nothing from which to infer that any of the other directors were controlled by the inside directors. The bare claim that the directors who served on the stock option and compensation committees should be viewed as interested because they are "substantially likely to be held liable" for their actions is not enough. The assertion that directors are interested because they are "substantially likely to be held liable" applies a standard employed in Delaware (see, e.g. Stone v Ritter, 911 A2d 362, 370 [Del 2006]); however, New York's Court of Appeals has declined to adopt "the Delaware approach to demand futility" (Marx, 88 NY2d at 198). Indeed, if we were to find demand futility wherever it was asserted that a majority of directors were "substantially likely to be held liable," then "all well-pled complaints would be able to establish demand futility. If facts outside of the pleadings may be considered in determining likelihood of liability,' a trial on the merits would be needed to determine whether to apply the futility exception"

(see In re InfoSonics Corp. Derivative Litig., 2007 WL 2572276, *7, 2007 US Dist LEXIS 66043, *20 [SD Cal, Sept. 4, 2007]). Nor is the assertion that these directors "completely disregarded or abdicated their responsibilities to manage the stock option plan" sufficient to fill the void.

The second ground on which demand futility may be established under Marx v Akers (88 NY2d at 198) is that "the directors failed to inform themselves to a degree reasonably necessary about the transaction." In this Court's recent decision in Matter of Comverse Tech., Inc. Derivative Litig. (56 AD3d 49 [2008], supra), we reinstated a shareholder derivative complaint involving the issuance of backdated stock options, concluding that the allegations established demand futility under the second test of Marx v Akers. In holding that the board and its compensation committee had failed to exercise reasonably appropriate oversight of the stock option granting process, we relied upon such specific assertions as (1) "unanimous written consents" for grants of stock options were sometimes presented to the compensation committee for signature more than a month after the grant date in circumstances where the stock price had risen dramatically in the intervening period, and yet were approved without question or inquiry; (2) compensation committee members orally approved option grants in direct violation of the company's bylaws; and (3) the compensation committee had a ...


Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.